Dialysis specialist FMC keeps FY guidance, shares fall

Fresenius SE & Co. KGaA

04/11/2025 08:35

** Shares in Fresenius Medical Care FMEG.DE fall 5.3% after the world's largest dialysis provider's Q3 adjusted results beat expectations but the company kept its 2025 guidance

** J.P. Morgan says FY guidance has been reiterated, but the Q3 beat alone implies an upgrade to consensus of around 1%

** "Q325 numbers mainly better but unadjusted slightly

below expectations," a local trader says

** J.P. Morgan says even if FMC Q3 results look decent, the market will likely remain cautious because of the risk of another big share sale by Fresenius SE FREG.DE

 (Reporting by Bartosz Dabrowski in Gdansk)

 ((bartosz.dabrowski@thomsonreuters.com; +48 58 7696560;))